Detalhe da pesquisa
1.
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
Breast Cancer Res
; 26(1): 69, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650031
2.
Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
Breast Cancer Res
; 26(1): 83, 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38790033